SMi Group is proud to present the 23rd annual industry leading summit on Pharmaceutical Pricing and Market Access, taking place on 11th & 12th October 2017 in Central London. Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); stakeholder collaboration; meaningful patient engagement opportunities; and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication. Highlights will include an exclusive opening keynote from the FDA and interactive training on Real World Evidence (RWE). Featured Speakers include: Lundbeck, FDA, Shire, Sobi, Teva, Grifols, Allergan, Sanofi and more! For more information visit the website at http://www.pharmaceuticalpricing.co.uk/gbi or contact the team on email: events@smi-online.co.uk or call +44 (0)20 7827 6000